Subject | Predicate |
aers:HYPOMAGNESAEMIA | aersVocab:reaction of |
aers:Hospitalization - Initial or Prolonged | aersVocab:outcome of |
aers:Involvement of BETNESOL [BETAMETHASONE SODIUM PHOSPHATE] in #8140850 | aersVocab:therapy of |
aers:Involvement of BETNESOL [BETAMETHASONE SODIUM PHOSPHATE] in #8140850 | aersVocab:involved in |
aers:Involvement of CALCIUM CARBONATE in #8140850 | aersVocab:therapy of |
aers:Involvement of CALCIUM CARBONATE in #8140850 | aersVocab:involved in |
aers:Involvement of COLECALCIFEROL in #8140850 | aersVocab:therapy of |
aers:Involvement of COLECALCIFEROL in #8140850 | aersVocab:involved in |
aers:Involvement of DEXERYL [GLYCEROL,PARAFFIN, LIQUID,WHITE SOFT in #8140850 | aersVocab:therapy of |
aers:Involvement of DEXERYL [GLYCEROL,PARAFFIN, LIQUID,WHITE SOFT in #8140850 | aersVocab:involved in |
aers:Involvement of DIAZEPAM in #8140850 | aersVocab:therapy of |
aers:Involvement of DIAZEPAM in #8140850 | aersVocab:involved in |
aers:Involvement of DOXYCYCLINE HCL in #8140850 | aersVocab:therapy of |
aers:Involvement of DOXYCYCLINE HCL in #8140850 | aersVocab:involved in |
aers:Involvement of ESOMEPRAZOLE MAGNESIUM in #8140850 | aersVocab:therapy of |
aers:Involvement of ESOMEPRAZOLE MAGNESIUM in #8140850 | aersVocab:involved in |
aers:Involvement of FORTIMEL in #8140850 | aersVocab:therapy of |
aers:Involvement of FORTIMEL in #8140850 | aersVocab:involved in |
aers:Involvement of LOPERAMIDE HCL in #8140850 | aersVocab:therapy of |
aers:Involvement of LOPERAMIDE HCL in #8140850 | aersVocab:involved in |
aers:Involvement of MAGNESIUM PIDOLATE in #8140850 | aersVocab:therapy of |
aers:Involvement of MAGNESIUM PIDOLATE in #8140850 | aersVocab:involved in |
aers:Involvement of POTASSIUM CHLORIDE in #8140850 | aersVocab:therapy of |
aers:Involvement of POTASSIUM CHLORIDE in #8140850 | aersVocab:involved in |
aers:Involvement of RACECADOTRIL in #8140850 | aersVocab:therapy of |
aers:Involvement of RACECADOTRIL in #8140850 | aersVocab:involved in |
aers:Involvement of SMECTA [AL+ HYDROX-MGCO3 GEL,AL+ MG+ SILIC,GL in #8140850 | aersVocab:therapy of |
aers:Involvement of SMECTA [AL+ HYDROX-MGCO3 GEL,AL+ MG+ SILIC,GL in #8140850 | aersVocab:involved in |
aers:Involvement of SORAFENIB (RAF KINASE INHIBITOR) in #8140850 | aersVocab:therapy of |
aers:Involvement of SORAFENIB (RAF KINASE INHIBITOR) in #8140850 | aersVocab:involved in |
aers:Involvement of TRIMEBUTINE in #8140850 | aersVocab:therapy of |
aers:Involvement of TRIMEBUTINE in #8140850 | aersVocab:involved in |
aers:Involvement of ULTRACET in #8140850 | aersVocab:therapy of |
aers:Involvement of ULTRACET in #8140850 | aersVocab:involved in |